Filing Details
- Accession Number:
- 0001415889-24-010011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-03 16:30:41
- Reporting Period:
- 2024-04-01
- Accepted Time:
- 2024-04-03 16:30:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-01 | 15,000 | $129.49 | 15,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-01 | 489 | $223.03 | 14,641 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-01 | 590 | $223.71 | 14,051 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-01 | 769 | $225.17 | 13,282 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-01 | 1,014 | $225.70 | 12,268 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-01 | 1,373 | $227.46 | 10,895 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-01 | 5,005 | $228.34 | 5,890 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-01 | 5,354 | $229.38 | 536 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-01 | 406 | $230.14 | 130 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-04-02 | 15,000 | $129.49 | 15,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-02 | 186 | $227.02 | 14,944 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-02 | 5,216 | $228.81 | 9,728 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-02 | 8,121 | $229.64 | 1,607 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-02 | 1,477 | $230.52 | 130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2024-04-01 | 15,000 | $0.00 | 15,000 | $129.49 |
| Common Stock | Stock Options | Disposition | 2024-04-02 | 15,000 | $0.00 | 15,000 | $129.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 432,529 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
| 417,529 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $222.185 to $223.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $223.25 to $224.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $224.555 to $225.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $225.56 to $226.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $226.85 to $227.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $227.89 to $228.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $228.895 to $229.875. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $230.03 to $230.185. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $228.22 to $229.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $229.225 to $230.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $230.255 to $230.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
